Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Azelaic Acid wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Mostly mechanism / observational
Top outcomes
Shared outcomes (1)
Outcomes where both Azelaic Acid and Tranexamic Acid (topical) have evidence — compare verdict strength side-by-side.
Topical only. OTC cosmetic azelaic acid is typically around 10%; prescription strengths are 15% gel/foam (rosacea) and 20% cream (acne), applied as a thin layer to clean skin once or twice daily. There is no oral, injectable, or systemic dose. For rosacea or persistent acne, the prescription form under a clinician is the evidence-based route. This library does not provide an ingestion protocol.
any
Leave-on topical gel, foam, or cream (OTC ~10%, or prescription 15-20%)
Topical use, typically ~2-5% tranexamic acid in a serum applied to areas of melasma once or twice daily, alongside daily sunscreen. There is no oral or systemic dose in this cosmetic context — the ingested medication is a separate prescription use with clotting-risk considerations. This library does not provide an ingestion protocol.
any
Leave-on topical serum (≈2-5% tranexamic acid)
Throughout
4-15 weeks
8-24 weeks
4-12 weeks
Throughout
8-12 weeks
Throughout
Throughout
Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies.
J Am Acad Dermatol (2003) · Rct · n=664
Two double-blind, vehicle-controlled phase III RCTs (664 patients total) of 15% azelaic acid gel twice daily for moderate papulopustular rosacea
A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial.
Arch Dermatol (2003) · Rct · n=251
Multicenter, double-blind, randomized head-to-head trial in 251 patients with moderate papulopustular rosacea over 15 weeks
Interventions for rosacea.
Cochrane Database Syst Rev (2015) · Systematic review
Cochrane review of 106 RCTs (13,631 participants) of rosacea treatments with GRADE quality assessment
Topical tranexamic acid as a promising treatment for melasma.
J Res Med Sci (2014) · Rct · n=50
Double-blind 12-week split-face RCT in 50 women: 3% topical TXA on one side vs 3% hydroquinone + 0.01% dexamethasone on the other, twice daily
The effectiveness and safety of 3% tranexamic acid cream vs. 4% hydroquinone cream for mixed-type melasma in skin of color: a double-blind, split-face, randomized controlled trial.
Acta Dermatovenerol Alp Pannonica Adriat (2024) · Rct · n=20
Double-blind 8-week split-face RCT in 20 skin-of-color subjects comparing 3% topical TXA cream vs 4% hydroquinone cream
Tranexamic acid as a therapeutic option for melasma management: meta-analysis and systematic review of randomized controlled trials.
J Dermatolog Treat (2024) · Meta analysis
Meta-analysis of 22 RCTs (1280 patients) of TXA delivered orally, topically, or by injection for melasma
Azelaic Acid has a higher evidence score (7.5/10 vs 6/10) and wins in 2 of 3 categories.
For even skin tone, Azelaic Acid has a higher relevance score (80 vs 70).
No known interactions between Azelaic Acid and Tranexamic Acid (topical) have been documented in our database. However, always consult a healthcare provider before combining supplements.